DSM to acquire Aland (China) to strengthen vitamin C position

Royal DSM has reached agreement to acquire Aland (HK) Holding, a Hong Kong-based company producing vitamin C in mainland China. Subject to customary conditions, the transaction is expected to close in the next 6–9 months.

DSM previously announced on 9 April 2014 that it was in exclusive discussions to acquire Aland. Acquiring Aland allows DSM to further strengthen its position in vitamin C.

Aland increases DSM's global footprint in vitamins for human nutrition & health, animal nutrition & health and personal care. DSM remains fully committed to its current vitamin C manufacturing facility in Dalry (Scotland, UK). The acquisition fully meets DSM's financial and strategic requirements. 

Aland was founded in 1990 and has a production facility in Jingjiang, Jiangsu Province in China. In 2013 the company realised net sales of about USD 90 million in vitamin C with around 1850 employees. The transaction excludes Aland's consumer health activities.

DSM plans to invest in Aland's production facilities for operational excellence including quality and environmental performance.